Un estudio no encuentra inflamación cerebral generalizada en casos de COVID persistente

28 de mayo de 2026

Reportado por IA

Investigadores en Finlandia no han hallado pruebas de una inflamación cerebral generalizada entre las personas con COVID persistente. En su lugar, los resultados vinculan los síntomas más graves con una mayor actividad en las regiones cerebrales relacionadas con las emociones y la memoria.

Un equipo de la Universidad de Turku examinó a 14 personas con COVID persistente mediante tomografías PET y resonancias magnéticas. Compararon los resultados con los escáneres de 11 voluntarios sanos y 13 pacientes con esclerosis múltiple. No aparecieron diferencias significativas en los marcadores de inflamación cerebral entre el grupo de COVID persistente y los controles sanos. Los pacientes con COVID persistente también mostraron mucha menos inflamación de la materia blanca que el grupo de esclerosis múltiple.

Study links a distinct CD14+ monocyte state to fatigue and breathing symptoms in long COVID

26 de marzo de 2026 Reportado por IA Imagen generada por IA Verificado por hechos

Researchers analyzing immune cells from people with long COVID have identified a distinct molecular state in CD14+ monocytes—labeled “LC-Mo”—that was more prevalent among patients whose initial COVID-19 illness was mild to moderate and that tracked with reported fatigue and respiratory symptoms, along with higher levels of inflammatory signaling molecules in blood plasma.

Severe COVID or flu may raise lung cancer risk years later

New research indicates that severe cases of COVID-19 or influenza can alter lung immune cells, potentially increasing cancer risk months or years afterward. The study, conducted by scientists at the University of Virginia, highlights the role of chronic inflammation in this process and emphasizes vaccination as a preventive measure. Findings suggest closer monitoring for affected patients to enable early detection.

UCSF study explains severe flu and COVID in older adults

3 de abril de 2026 Reportado por IA

Researchers at the University of California, San Francisco have identified how aging lungs contribute to severe flu and COVID-19 outcomes in older adults. Their study shows that lung fibroblasts trigger excessive inflammation, forming damaging clusters of immune cells. The findings, published in Immunity on March 27, suggest potential new treatments.

Salud

Study links major depression in young adults to altered cellular energy patterns in brain and blood

Salud

Large VIVID trial finds high-dose vitamin D3 did not lessen acute COVID-19 severity, but adherence analysis suggests possible long COVID signal

Salud

Stroke prompts rejuvenation-like changes in undamaged brain areas

USC researchers identify compounds targeting Alzheimer’s brain inflammation

Scientists at the University of Southern California have found experimental compounds that may reduce harmful brain inflammation associated with Alzheimer’s disease. The work focuses on the enzyme cPLA2 and people who carry the high-risk APOE4 gene.

Study links monocyte “biological aging” in blood to emotional depression symptoms in women with and without HIV

4 de mayo de 2026 Reportado por IA Verificado por hechos

A study of 440 participants from the Women’s Interagency HIV Study found that accelerated epigenetic aging in monocytes—an immune cell type—tracked more closely with emotional and cognitive depression symptoms such as hopelessness and loss of pleasure than with physical symptoms like fatigue. The work, published in The Journals of Gerontology: Series A, adds evidence that cell-type-specific aging measures could contribute to future biological tools to complement symptom-based depression screening, though researchers say more validation is needed before clinical use.

9 de junio de 2026 02:14

Un estudio no encuentra inflamación cerebral generalizada en casos de COVID persistente

Artículos relacionados

Study links a distinct CD14+ monocyte state to fatigue and breathing symptoms in long COVID

Severe COVID or flu may raise lung cancer risk years later

UCSF study explains severe flu and COVID in older adults

Study links major depression in young adults to altered cellular energy patterns in brain and blood

Large VIVID trial finds high-dose vitamin D3 did not lessen acute COVID-19 severity, but adherence analysis suggests possible long COVID signal

Stroke prompts rejuvenation-like changes in undamaged brain areas

USC researchers identify compounds targeting Alzheimer’s brain inflammation

Study links monocyte “biological aging” in blood to emotional depression symptoms in women with and without HIV

Home-based exercise program may ease “chemo brain” symptoms during chemotherapy, Phase II trial suggests

Texas A&M nasal spray reverses brain aging in study

Cochrane review questions benefits of anti-amyloid Alzheimer’s drugs

Personalized treatment plans improve early dementia symptoms

Fluvoxamine eases severe fatigue in long COVID patients

Severe infections raise dementia risk in large Finnish study

Study links blood-brain barrier damage to CTE in athletes

Pre-pandemic ill health common among those with postcovid

Este sitio web utiliza cookies